Granulocyte Colony Stimulated Factor
PreclinicalSmall molecule
Granulocyte Colony Stimulated Factor is one of 33 small molecule programs targeting Granulocyte Colony Stimulating Factor. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
32
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
46 competitors in Pregnancy
#DrugCompanyPhaseTrials
1Femara
NovartisApproved
Bayer Aspirin
BayerApproved
Marinol
Jazz PharmaceuticalsApproved
Rayos
RRoxane Laboratories
Approved
Pifeltro
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Approved
BEYFORTUS
SanofiPhase 3
Dihydroartemisinin-Piperaquine
GSKPhase 3
Monoferric
PPharmacosmos A/S
Phase 3
Cimzia
UCBPhase 2
Sulfadoxine Pyrimethamine
PfizerPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Granulocyte Colony Stimulating Factor1 trial
The Effect of Granulocyte Colony Stimulating Factor Versus Human Chorionic Gonadotropin in Females With a History of RIF
Unknown status·—·N/A·NCT04604054·100 enrolled
Pregnancy1 trial
Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI
Unknown status·—·N/A·NCT04606082·200 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- AAl-Azhar University